Basic and Clinical Promotion Program of Anhui Medical University (China) (No. 2023xkjT039). Disclaimer: AlphaGalileo is not ...
Selpercatinib in RET Fusion–Positive Non–Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial 3'RNA sequencing was performed in 1,733 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback